HENRY SCHEIN, INC. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $13.2B |
| Gross margin | 31.1% |
| Operating income | $653.0M |
| Net income | $398.0M |
| Diluted EPS | $3.27 |
| Cash & equivalents | — not reported |
| Total assets | $11.2B |
| Long-term debt | $2.3B |
Key takeaway
Henry Schein operates as a global health care distributor and specialty products/technology provider, serving over one million dental and medical customers across 34 countries.
🔒 4 more takeaways in the full analysis
Beneath the surface
The filing discloses $16 million in intangible asset impairment and $103 million in contingent consideration liability changes tied to acquisitions, both of which can weigh on reported operating income without being called out in headline figures.
🔒 4 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 8 more findings — plus insider trades, activist stakes, and 8-K events for HSIC.
Read the full analysis free Free account · 5 full analyses included · no card required